Breaking News

Ascend Gene & Cell Therapies Launches with $130M of Funding

Offers process development, clinical manufacturing, analytical, and regulatory support for advanced modalities requiring flexible CMC services.

Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety, and cost enabling better reach for gene therapy technologies, launched as a facilitator for gene therapy companies to help translate product ideas into viable clinical programs. Ascend offers process development, clinical manufacturing, and analytical and regulatory support for biotech companies working in advanced modalities requiring flexible CMC services. Original...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters